Hypertension: Understanding the causes, symptoms, and effective management

pharmanewsdaily- February 23, 2025 0

Hypertension, commonly known as high blood pressure, is a chronic condition where the force of blood against the artery walls is persistently elevated. While often ... Read More

High blood pressure may accelerate memory loss, study finds

pharmanewsdaily- February 2, 2025 0

A growing body of research suggests that high blood pressure may significantly increase the risk of memory loss, raising concerns about the long-term impact of ... Read More

Hypertension: Understanding the symptoms, causes, and treatment of high blood pressure

pharmanewsdaily- January 18, 2025 0

Hypertension, or high blood pressure, is a pervasive medical condition that affects millions worldwide. Often referred to as the "silent killer," it frequently progresses without ... Read More

Urinary diseases and disorders: Causes, symptoms, and management

pharmanewsdaily- January 5, 2025 0

The urinary system is one of the body’s most vital regulatory networks, ensuring the removal of toxins, maintenance of fluid balance, and stability of electrolytes. ... Read More

Recor Medical launches Paradise Ultrasound Renal Denervation System in US

Pallavi Madhiraju- November 11, 2023 0

Recor Medical, Inc., and its parent company, Otsuka Medical Devices Co., Ltd., have announced the first commercial uses of the Paradise Ultrasound Renal Denervation (uRDN) ... Read More

FDA approves Recor Medical’s Paradise Ultrasound RDN System for hypertension treatment

Pallavi Madhiraju- November 8, 2023 0

The U.S. Food and Drug Administration (FDA) has granted approval to Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., for the ... Read More

Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial

Pallavi Madhiraju- September 10, 2023 0

Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their Phase 2 study KARDIA-1. The investigational RNAi ... Read More

BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India

Pallavi Madhiraju- July 26, 2023 0

BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard ... Read More

FDA greenlights Granules India’s Metoprolol Succinate ER tablets

Pallavi Madhiraju- June 13, 2023 0

Granules India Limited announced its receipt of US Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) of Metoprolol Succinate Extended-Release ... Read More

AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn

Raghuram Kadari- January 10, 2023 0

AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, ... Read More

1210 / 16 Posts